The Department of Molecular Anatomical Pathology, PathWest Laboratory Medicine WA (PathWest) performs comprehensive genomic profiling (CGP) of solid tumours for patients within Western Australia using Next Generation Sequencing (NGS) technology. This service provides complex analysis of somatic gene mutations, rearrangements and aberrations in cancer specimens for the purpose of patient diagnosis, prognosis and personalised treatment modalities. The introduction of the Hamilton STAR platform will directly reduce the turnaround time of testing, interpretation and reporting of patient results relating to sample preparation, allowing cancer patients to receive personalised treatment much sooner, and combat demand increases. PathWest is hereby seeking to purchase an automated liquid handling workstation for processing NGS assays, including post-warranty service and maintenance for up to seven years.
Public award record
Provision of one (1) Bio-Strategy Hamilton STAR Robotic Liquid Handling Workstation for Next Generation Sequencing (NGS) for PathWest Laboratory Medicine WA
- Location
- Perth Metropolitan
- Public buyer
- PathWest Laboratory Medicine WA
AWARD DETAILS
- Buyer
- PathWest Laboratory Medicine WA
- State
- WA
- Published
- Contract start
- —
- Category
- Laboratory and scientific equipment - (100%)
- Value
- $906.1k
- Value type
- (Estimate)
- Procurement method
- Direct Sourcing
- Record updated